# A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)

> **NCT01028729** · PHASE4 · UNKNOWN · sponsor: **Simcere Pharmaceutical Co., Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** Endostar
- **DRUG:** Gemcitabine-Cisplatin chemotherapy

## Key facts

- **NCT ID:** NCT01028729
- **Lead sponsor:** Simcere Pharmaceutical Co., Ltd
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2009-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01028729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01028729, "A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01028729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*